(From left) Sung Hyun Paick, President of the Korean Society of Endourology and Robotics and Joon Koo Kim, CEO of meerecompany.
meerecompany (CEO Joon Koo Kim) has signed a memorandum of understanding (MOU) with the Korean Society of Endourology and Robotics (President Sung Hyun Paick) for the training of future robotic surgery medical staff and the cooperation in domestic and overseas advancement of Revo-i Robotic Surgical System.
At the agreement ceremony held on the 30th of June at Gwanggaeto Hall, Sejong University, Professor Sung Hyun Paick, the President of the Korean Society of Endourology and Robotics (KSER), the Department of Urology at Konkuk University Medical Center, Professor Kyung Jin Oh, Chonnam National University Medical School, Professor Phil Hyun Song, College of Medicine, Yeungnam University, Professor Woong Bin Kim, Soonchunhyang University College of Medicine, Professor Sung Gu Kang, Korea University College of Medicine, Joon Koo Kim, CEO of meerecompany, Ho Kun Lee, Head of Surgical Robot division, executive vice president, and other key stakeholders attended.
According to this agreement, meerecompany and the Korean Society of Endourology and Robotics will mutually cooperate to develop robotic surgery techniques in Korea. meerecompany operates the Revo-i Robotic Surgery Innovation Center as a systematic educational facility, and the Korean Society of Endourology and Robotics prepares and conducts robotic surgery training programs for medical staff in the urology department. In addition, the two institutions agreed to cooperate on ways to publicize the product power and technology of Revo-i.
A Revo-i hands-on session was also held as part of the mutual cooperation following the signing of the MOU.
Established in 1996, the KSER is a representative society of minimally invasive surgery in urology. KSER is promoting academic research and technological development in the fields related to urological treatment and extracorporeal shock wave lithotripsy using endoscopes and mechanical equipment.
Sung Hyun Paick, President of KSER, said, “Recently, interest in Korean surgical robots has been high in the global market. With the signing of this MOU, it is meaningful to provide high-quality robotic surgery training to medical staff in urology and at the same time to have an opportunity to contribute to the development of domestic surgical robot technology.”
meerecompany CEO Joon Koo Kim said, “Revo-i Robotic Surgery Innovation Center is equipped with a world-class robotic surgery training environment, so we expect that it will contribute to the development of robotic surgery skills for medical staff. We will make efforts to contribute to the development of domestic urology and robotic surgery by expanding practical cooperation.”
Officials from both organizations pose for a commemorative photo after signing the memorandum of understanding.
Meanwhile, Revo-i is a surgical robot successfully developed and commercialized for the first time in Korea by meerecompany. In May 2021, it was designated as the 10th Innovative Medical Device by the Ministry of Food and Drug Safety and was recognized for its advanced technology in the field of medical robot technology. In addition, it has been introduced to various medical institutions in Korea, including Severance Hospital, a tertiary general hospital, and has secured clinical safety and reliability in various indications.